Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsWorld

Russia completes clinical trials of second potential COVID-19 vaccine

The institute completed early-stage human trials, known as Phase II, earlier this month.

September 30, 2020 / 02:15 PM IST

Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

The institute completed early-stage human trials, known as Phase II, earlier this month.

Follow our full coverage of the coronavirus pandemic here.
Reuters
first published: Sep 30, 2020 02:00 pm
Sections
ISO 27001 - BSI Assurance Mark